iShares US Pharmaceuticals ETF (NYSEARCA:IHE) declared a quarterly dividend on Wednesday, March 20th, Wall Street Journal reports. Stockholders of record on Thursday, March 21st will be given a dividend of 0.5565 per share on Tuesday, March 26th. This represents a $2.23 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date is Wednesday, March 20th. This is a boost from iShares US Pharmaceuticals ETF’s previous quarterly dividend of $0.35.
Shares of iShares US Pharmaceuticals ETF stock traded down $1.15 during trading on Wednesday, reaching $154.16. The company’s stock had a trading volume of 6,510 shares, compared to its average volume of 11,500. iShares US Pharmaceuticals ETF has a one year low of $131.91 and a one year high of $170.26.
ILLEGAL ACTIVITY NOTICE: This report was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another domain, it was stolen and republished in violation of international copyright law. The original version of this report can be read at https://www.dispatchtribunal.com/2019/03/20/ishares-us-pharmaceuticals-etf-ihe-increases-dividend-to-0-56-per-share.html.
About iShares US Pharmaceuticals ETF
iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.
Read More: What is a Derivative?
Receive News & Ratings for iShares US Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares US Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.